Anteris Technologies Ltd
AVR.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$929.62M
Close$
$-0.04
100.4% downside
Current Fair Value
100.4% downsideOvervalued by 100.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $929.62 Million |
|---|---|
| Enterprise Value | $675.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.61 |
| Beta | 0.73 |
| Outstanding Shares | 90,214,603 |
Return
| Return on Equity | -71.69% |
|---|---|
| Return on Assets | -66.13% |
| Return on Invested Capital | -72.37% |
Valuation & Multiples
| P/E Ratio | -2.57 |
|---|---|
| PEG | -0.91 |
| Price to Sales | - |
| Price to Book Ratio | 4.78 |
| Enterprise Value to Revenue | 149.89 |
| Enterprise Value to EBIT | -3.67 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$2.11 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Anteris Technologies Ltd
174 employees
CEO: Wayne Geoffrey Paterson Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in a...